Dr Louise Schaper at PSA25[/caption]
WHO puts ‘temporary pause’ on hydroxychloroquine trial for coronavirus patients
A trial of hydroxychloroquine for COVID-19 treatment has been suspended after researchers found patients receiving the drug were at higher risk of heart problems and death.
Better COVID-19 communication needed, PSA tells Vic govt committee
Insufficient or unhelpful communication from authorities has been the most frustrating aspect of the COVID-19 crisis since restrictions started, according to Victorian pharmacists.
Preparing to vaccinate children under 12 against COVID-19
On 5 December, the Therapeutic Goods Administration (TGA) provisionally approved Pfizer’s COVID-19 vaccine for children over 5 years of age.
Diary of a pharmacist in lockdown
Accredited pharmacist Kay Morey MPS has been in the thick of the COVID-19 crisis. She shares what life has been like during the past 7 months.
Why pharmacist accreditation is important
With demand for pharmacists in aged care set to rise, and the removal of the re-accreditation fee, there has never been a better time to broaden your scope of practice through accreditation.
Determinants of health and reducing health inequity
Health can be defined in many ways and is influenced by context, culture and an individual's belief systems.
